NCT06955533

Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 64 (actual)
• Sponsor: Ain Shams University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study was a randomized clinical trial conducted on 64 Egyptian patients from the outpatient clinic at Ain Shams University Hospital over a six-month period from 3/2024 to 9/2024.The study population was randomized into 2 groups. Group A included 32 patients with stent related symptoms receiving double doses of tamsulosin (Tamsulin® 0.4 mg 2 capsules taken together per day) and Solifenacin 10mg (Sofenacin® 10mg tab taken once daily).Group B included 32 patients with stent related symptoms receiving a standard dose of tamsulosin (0.4 mg once daily) and solifenacin (5 mg once daily).

Conditions

• Stent Related Symptoms

Interventions

Type	Name	Description
DRUG	Double dose tamsulosin and solifenacin	Odd number
DRUG	Single dose tamsulosin and solifenacin	Even number

Timeline

• Start date: 2024-04-01
• Primary completion: 2024-08-01
• Completion: 2024-08-01
• First posted: 2025-05-02
• Last updated: 2025-05-02

Locations

1 site across 1 country: Egypt